BREWIN DOLPHIN LTD - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 86 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$6,367
+42.3%
11,3300.0%0.00%0.0%
Q4 2018$4,473
-22.3%
11,3300.0%0.00%0.0%
Q3 2018$5,756
-76.9%
11,3300.0%0.00%
-66.7%
Q2 2018$24,92611,3300.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Empery Asset Management, LP 4,262,409$2,430,0005.07%
CVI Holdings, LLC 5,171,896$2,948,0000.20%
PRIVATE CAPITAL MANAGEMENT LLC 937,237$534,0000.18%
CVA Family Office, LLC 1,137,920$649,0000.16%
ACT CAPITAL MANAGEMENT, LLC 291,500$166,0000.12%
Cypress Capital Management LLC (WY) 196,775$112,0000.09%
Willis Investment Counsel 2,181,840$1,244,0000.06%
NTB Financial Corp 146,100$83,0000.06%
Helen Stephens Group, LLC 117,222$67,0000.05%
SRS Capital Advisors, Inc. 629,172$359,0000.05%
View complete list of AMPIO PHARMACEUTICALS INC shareholders